Arizona State Retirement System Raises Stake in Senseonics Holdings, Inc. (NYSEAMERICAN:SENS)

Arizona State Retirement System boosted its holdings in shares of Senseonics Holdings, Inc. (NYSEAMERICAN:SENS – Get Rating) by 23.9% during the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 124,771 shares of the company’s stock after purchasing an additional 24,058 shares during the period. Arizona State Retirement System’s holdings in Senseonics were worth $129,000 as of its most recent filing with the SEC.

Several other hedge funds also recently made changes to their positions in the company. BlackRock Inc. lifted its holdings in shares of Senseonics by 3.3% in the third quarter. BlackRock Inc. now owns 31,324,927 shares of the company’s stock valued at $41,350,000 after purchasing an additional 1,003,971 shares in the last quarter. Vanguard Group Inc. lifted its holdings in shares of Senseonics by 6.5% in the first quarter. Vanguard Group Inc. now owns 21,431,413 shares of the company’s stock valued at $42,221,000 after purchasing an additional 1,306,932 shares in the last quarter. State Street Corp raised its position in shares of Senseonics by 11.6% in the second quarter. State Street Corp now owns 14,097,923 shares of the company’s stock valued at $14,521,000 after buying an additional 1,467,601 shares during the last quarter. Northern Trust Corp raised its position in shares of Senseonics by 1.2% in the second quarter. Northern Trust Corp now owns 4,055,471 shares of the company’s stock valued at $4,177,000 after buying an additional 49,169 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. raised its position in shares of Senseonics by 2.6% in the first quarter. Charles Schwab Investment Management Inc. now owns 3,014,693 shares of the company’s stock valued at $5,939,000 after buying an additional 77,338 shares during the last quarter. Institutional investors and hedge funds own 23.34% of the company’s stock.

Senseonics Stock Performance

Shares of SENS opened at $0.66 on Friday. The company has a market capitalization of $314.36 million, a price-to-earnings ratio of -3.85 and a beta of 0.87. The company’s 50 day simple moving average is $0.93. The company has a debt-to-equity ratio of 0.58, a quick ratio of 9.68 and a current ratio of 10.25. Senseonics Holdings, Inc. has a twelve month low of $0.54 and a twelve month high of $2.44.

Senseonics (NYSEAMERICAN:SENS – Get Rating) last released its quarterly earnings results on Wednesday, March 15th. The company reported ($0.01) EPS for the quarter, beating analysts’ consensus estimates of ($0.05) by $0.04. Senseonics had a net margin of 314.37% and a return on equity of 266.98%. The company had revenue of $5.57 million for the quarter, compared to analyst estimates of $4.99 million. On average, sell-side analysts anticipate that Senseonics Holdings, Inc. will post -0.13 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Separately, StockNews.com started coverage on shares of Senseonics in a research report on Thursday, May 18th. They issued a “sell” rating for the company.

About Senseonics

(Get Rating)

Senseonics Holdings, Inc engages in the design, development, and commercialization of an implantable continuous glucose monitoring system for people with diabetes. Its primary product is the brand Eversense, a glucose monitoring device which includes sensors, smart transmitters, and mobile applications.